Digital Health & HealthTech
Unique perspective into the digital transformation of healthcare’s eco-systemContact Us
Digital Health & HealthTech resides at the intersection of healthcare and technology. Companies in this sector offer solutions to advance healthcare’s triple aim – improving clinical outcomes, optimizing costs and engaging the consumer.
We have a deep understanding of this growing sector and provide a uniquely tailored combination of strategic guidance, insights and capital that will enable Digital Health & HealthTech companies to address the unmet needs of our healthcare ecosystem.
Our leading team of professionals leverage their knowledge, experience and singular healthcare focus to help our clients define and achieve their strategic, capital markets and investment objectives.
Related Banking Team
Senior Managing Director, HealthTech and Digital Health
Jon Swope is a Senior Managing Director in Investment Banking at SVB Securities and leads the firm’s Digital Health and HealthTech practice. He also covers Managed Care and Payor Services companies. With over 12 years of healthcare investment banking experience, Jon has worked extensively with both private and publicly listed firms on mergers & acquisitions, equity offerings (IPOs, follow-ons and private placements), acquisition financings and debt financings.
Jon joined SVB Securities in 2021 from BofA Securities, most recently as Managing Director in the Global Healthcare Investment Banking Group. His prior work experience includes positions at Greenhill & Co., Bain & Company and WTW.
He holds a B.A. (cum laude) from Duke University and an M.B.A. from Duke University’s Fuqua School of Business.
Related Research Team
Senior Managing Director, Healthcare Technology and Distribution
Stephanie Davis, CFA, is a Senior Research Analyst at SVB Securities covering Healthcare Technology and Distribution. She has over a decade of experience covering the Healthcare IT and IT Services sectors and leads the firm’s digital health research efforts.
Prior to joining the firm, Stephanie worked at Citibank, where she led coverage for the Healthcare IT sector, including the electronic health record companies, payer-facing and provider-facing IT players. Before Citi, she was an Equity Research Analyst at J.P. Morgan and, earlier in her career, was an Investment Banking Analyst at Sonenshine Partners.
In 2019, Stephanie was recognized as a Runner-Up for Health Care Technology and Distribution on Institutional Investor’s All America Research Team and was included in Business Insider’s “Rising Stars of Equity Research” in 2017.
She earned a B.A. in Economics and Mathematics from Columbia University and is a CFA charter holder.
Related Management Team
Global Co-Head of Investment Banking and Global Co-Head of Healthcare Investment Banking
Barry Blake is the Global Co-Head of Investment Banking, and Global Co-Head of Healthcare Investment Banking at SVB Securities. In this role, he co-leads the firm’s healthcare investment banking strategy and initiatives, with a focus on Healthcare Services & Technology. With 25 years of experience, he has built extensive relationships and has proven expertise in healthcare services, medical devices and tools/diagnostics, leveraged finance, and with financial sponsors. Leading the Healthcare Services team at SVB Securities, he has advised on numerous transactions, including the sale of LHC Group to Optum Health, a UnitedHealth Group Company, for $6B.
Barry joined the firm in 2021 from Guggenheim Securities where he was a Senior Managing Director focused on advising healthcare services companies. While at Guggenheim he advised on many transactions including, but not limited to, the $10B sale of Envision to KKR; the $4B sale of Kindred Healthcare to a consortium comprised of TPG, Welsh Carson and Humana; the $2.4B sale of American Medical Response to KKR and the $1B sale of Almost Family to LHC Group. Prior to this, he was the Head of Global Healthcare Mergers and Acquisitions for Citigroup. While at Citigroup he worked on many transactions including, but not limited to, the $34B acquisition of Medco by Express Scripts. He also worked in the M&A and Healthcare groups at Morgan Stanley, JP Morgan and Lehman Brothers. While at JP Morgan he advised on many transactions including, but not limited to, the $4.8B acquisition of NextRx from Wellpoint by Express Scripts.
Barry earned his Bachelor of Arts in Economics from Hendrix College, and his Masters of Business Administration with high distinction from the Amos Tuck School at Dartmouth College.
He has served as a member of the Board of Trustees for each of The Hopkins School in New Haven, CT and Hendrix College in Conway, AR.
Director, Business Manager
Christian Clark is a Director and Business Manager of Investment Banking at SVB Securities. Mr. Clark is responsible for managing the group’s overall operations including strategic planning, financial and business reporting and analytics, people management and recruiting. He supports Healthcare Services & Technology and MD&D investment banking teams.
Mr. Clark joined the firm in 2018 as the Business Manager for Equity Research. He was responsible for managing the Equity Research side of client strategy and for leading many key strategic initiatives in product, process and business development. He was promoted to Associate Director of Equity Research during his time in Equity Research.
Prior to SVB Securities, Mr. Clark worked at Credit Suisse and held a variety of business and strategy positions within the Equities division. Prior to this role, he was a Fixed Income client consultant at Bloomberg LP.
Mr. Clark earned his B.S. in Finance (Summa Cum Laude) from Pennsylvania State University.
Senior Managing Director, Director of Research
Jim Kelly is a Senior Managing Director, Director of Research at SVB Securities. Mr. Kelly is responsible for product management, analyst development and equity strategy.
Prior to joining SVB Securities in 2015, Mr. Kelly worked at Credit Suisse, where he served in research management as an Associate Director of Equity Research in New York and was responsible for leading key, strategic initiatives in research product and process development. Prior to his ADOR role at Credit Suisse, Mr. Kelly spent 13 years in Equity Research covering the US Pharmaceuticals industry for Lehman Brothers, Goldman Sachs and Credit Suisse First Boston.
Mr. Kelly received his M.B.A. from Columbia Business School and earned his B.S. in Mechanical Engineering from Lehigh University. Mr. Kelly also serves on the board of the Lehigh Business School Dean’s Advisory Council.
Managing Director, Associate Director of Research
Julia Belladonna is a Managing Director, Associate Director of Research at SVB Securities.
Julia joined the firm in 2021 from Credit Suisse where she spent 20+ years in a variety of roles, most recently as the COO of Global Economics for their Institutional client & Private Wealth Management businesses. She brings over two decades of experience in financial markets, business and talent management, international regulatory requirements, and operations. She has excelled in managing complex groups, collaborating across business units, and developing strategies to deliver research to clients. Prior to Credit Suisse, she was an Industry Analyst at Merrill Lynch.
Julia earned a B.A. in Applied Mathematics and History from Williams College and an M.B.A. in Finance from Columbia Business School.